NCT04189835View on ClinicalTrials.gov

EVITA Study - Epstein-Barr Virus Infection MoniToring in RenAl Transplant Recipients

Active, not recruitingOBSERVATIONAL
Enrollment

509

Participants

Timeline

Start Date

January 3, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2029

Conditions
EBV InfectionEBV ViremiaEpstein-Barr Virus Associated Lymphoproliferative DisorderPost-transplant Lymphoproliferative Disorder
Interventions
DIAGNOSTIC_TEST

EBV DNA in whole blood and plasma

Consecutive measurements of EBV DNA in whole blood and plasma

Trial Locations (3)

Unknown

Aarhus University Hospital, Aarhus

Odense University Hospital, Odense

Rikshospitalet, Oslo Universitetssykehus, Oslo

All Listed Sponsors
collaborator

Rikshospitalet University Hospital

OTHER

collaborator

Aarhus University Hospital

OTHER

collaborator

Odense University Hospital

OTHER

lead

University of Aarhus

OTHER